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O nce thought to be safe, there is mounting evidence that human exposure to chemi-cals at low levels can be harmful. The ex-posures are linked with adverse biological effects, including endocrine disruption (i), 
chemical sensitivity (2), and cancer (3). Prior sus-
ceptibility of an individual, whether inborn or en-
vironmentally induced, followed by other lifetime ex-
posures, can cause irreversible injury. Unfortunately, 
although emerging scientific knowledge associated 
with these exposures indicates a need to change the 
way we think about chemicals and health, new the-
ories 3X6 slow to emerge (see box on next page) (4). 
^fe are just now beginning to recognize the link 
between chemicals and new public health prob-
lems that challenge the tenets of traditional toxicol-
ogy and medicine These include birth defects and 
other damage due to developmental toxicants au-
toimmune diseases (including lupus scleroderma 
and Sjogren's Syndrome) chronic conditions in chil-
dren (such as attention deficit hyperactivity disor-
der depression and asthma) that have become more 
prevalent in the past few decades chemical sensi-
tivity including its overlaps with sick building syn-
drome unexplained illnesses of Gulf War veterans 
chronic farieup svndromp fibromyalgia toxic 
pnhalnnafhv nrl np links to canrpr incltiHt'np-
, ( , , , A ' 
childhood cancers. 
Problem characterization 
These emerging health problems are characterized 
by common threads that provide a new perspective 
on disease. 
Nature: They are a departure from classic dis-
eases such as tuberculosis and heart disease. Com-
munication systems or networks—including the en-
docrine system, the immune system, and the 
neurological system—rather than specific organs of 
the body, appear to be targeted. 
Cause: No ssngle cause has been identified for rach 
of these conditions. Often there are no clear biornar-
kers for either exposure or disease. Consequently, 
classical epidemiology is less able to identify sus-
ceptible or sensitive subgroups. 
Stages: Disease becomes manifest after two or 
more stages or events occur. For example, some can-
cers may proceed first by initiation—a mutation that 
alters the genetic material of the cell—followed by 
the promotion of cancer cells to a recognizable tu-
mo.. These stages can involve different chemicals, ra-
diation, or viruses. It has been hypothesized that Tox-
icant-Induced Loss of Tolerance (TILT), a new theory 
of disease, leading to chemical sensitivity, also pro-
ceeds via a two-stage process: an initial exposure to 
high levels of certain chemicals (or repeated expo-
sures at lower levels), followed by triggering of symp-
toms by everyday chemical exposures at levels that 
do not appear to affect most people (2). 
Time: The time between the ffrst and subsequent 
stages of disease can be long enough to obscure the 
connection between exposures and ultimate dis-
ease. The latency of chemically caused cancer is mea-
sured in years. Observable reproductive system fail-
ure can occur years after endocrine disruption. 
Chemical sensitivity reportedly can develop months 
after the initial exposure and remain manifest for 
years. The timing of the initiating doses appears im-
portant. Loss of tolerance does not always require a 
high initial dose; smaller doses, strategically timed, 
might also cause pathological loss of tolerance. 
Nonclassical lxplanation: Classical approaches and 
models used in both toxicology and epidemiology, 
premised on single agents disrupting individual 
organs, do not explain these diseases. Moreover, the 
relationship between the initiating exposure and ul-
timate health effects is not monotonic. This is illus-
trated in the recent work of Fred vom Saal on the en-
docrine-disrupting effects of bisphenol A, as discussed 
in Hileman's article (5). Endocrine disruption (ED), 
TILT, and some cancers appear to represent a fail-
ure in functional and adaptive processes in impor-
tant systems or networks as a result of chemical ex-
posures at concentrations 3 to 6 orders of magnitude 
lower than those associated with classical toxic ef-
fects in normal individuals. Moreover individuals ex-
posed below "safe" thresholds to multiple xenobiot-
ics simultaneously as in a sick building tire ciffected. 
Disease processes: Endocrine disruption (ED), TILT, 
and some cancers may be interrelated. ED disrupts 
normal development, and possibly the immune sys-
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tem, which results in increased susceptibility to cer-
tain cancers. ED might also affect the neurological 
system, leading to increased susceptibility to sensi-
tization by chemicals. TILT manifests itself as a loss 
of tolerance to everyday chemical, food, and drug ex-
posures in affected persons, possibly leaving these 
individuals more susceptible to other diseases. Just 
as the general category of infectious diseases en-
compasses a diverse disease spectrum involving dif-
ferent organisms (which affect different organs via 
different specific disease mechanisms), TILT may arise 
from different chemical exposures (which, like the 
infectious diseases, could affect different organ sys-
tems via different specific disease mechanisms). With 
TILT key systems of the body appear to lose their abil-
ity to adapt to low-level chemical exposures Fi~ 
nally cancer proceeds when adaptive, homeostatic 
repair processes and the immune system no longer 
function as they should although the cause of this 
loss of protective function is not well understood 
Framework for response 
A systems-focused approach to disease is needed to 
fashion policy responses. Lack of clear biomarkers 
and the time lag between initiating exposures and 
ultimate disease make it technically and politically 
difficult to develop evidence needed for regulating 
many chemicals and industrial processes or to re-
solve compensation issues. We must therefore con-
sider adoption of the Precautionary Principle (act-
ing preventively in the face of uncertainty), erring on 
the side of caution. 
Applying the Precautionary Principle requires 
stakeholder education, political courage, and con-
viction. Concern that new problems—such as as-
bestos-related cancer, and the toxic effects of ben-
zene, lead, and persistent pesticides—are emerging 
generally has begun with only a modest suggestion 
of evidence. When strengthened by further informa-
tion, concern grows. Often, early warnings warranted 
heeding: Predictions were in the right direction, if not 
understated. Unfortunately, although precaution-
ary actions were justified, too much time elapsed be-
fore they were implemented, and harm occurred. 
Some damage has already been done by endocrine-
disrupting chemicals, but a growing recognition of the 
need to address problems now presents an opportu-
nity to act quickly. Some aspects of endocrine disrup-
tion and other systemic damage or injury remain un-
certain, and potentially regulated industries are 
opposed to costly controls. Nonetheless, rapid in-
tervention to prevent the next generation of devel-
opmentally compromised or chemically intolerant in-
dividuals is possible and advisable. Uncertainty and 
economic concerns may appear to pose a dilemma 
for environmental legislators and regulators (diey may 
fail to regulate a chemical that is later discovered to 
be harmful or they may at cost to industry and con-
sumers, regulate a chemical and later find that the 
chemical is safe to use) but potentially harmful 
chemicals should be regulated when scientific evi-
dence although imperfect is compelline 
A policy response consistent with a precautionary 
view presents specific challenges: Policies must be har-
Evolution of scientific knowledge 
• Ignore departures from the existing framework of beliefs. 
• Deny that an anomaly exists; blame it on faulty observation or 
testing error; deride the proponents of the new viewpoint. 
• Acknowledge the anomaly, but call it "idiopathic." 
• Try to explain the anomaly with the existing framework, some-
times by making minor adjustments. 
• Seek alternative viewpoints to contradict or minimize the one pro-
posed. 
• Recognize the new viewpoint as valid, but within a narrow con-
text relegated to "exceptions." 
• Accept the new viewpoint as offering some explanatory power, 
but retain the old viewpoint, too. 
• Discredit the old viewpoint; deride any attempt to reinstate or 
rehabilitate it. 
• Accept the new viewpoint with enthusiasm. 
• Begin again. 
Source: Reference 2, adopted from Reference 4. 
monized and coordinated among the major stakehold-
ers. A new corporate stewardship is required, one that 
is harmonized with the customers' and the public's ex-
pectations that companies will adhere to the Precau-
tionary Principle. Rather than serving as an arbiter or 
mediator of conflicts among stakeholders, govern-
ment must return to its role as a trustee of the envi-
ronment, public health, and sustainability, and direct 
its interventions and research support to all phases of 
multistage diseases, for example, to promoters, as well 
as initiators of cancer. Media representatives must ac-
curately report the complex evolution of scientific un-
derstanding. Public interest groups and nongovern-
mental organizations should strengthen linkages among 
disparate groups and continue their role as educators 
and advocates for precautionary protections. The in-
ternational community must commit to a program of 
relevant research and to the establishment of multi-
lateral environmental agreements, such as the pro-
posal to ban persistent organic pollutants. These agree-
ments should not result in banning endocrine-
disrupting chemicals by substituting chemicals that 
produce other harmful effects or that put workers at 
significant risk and the strategy for dealing with en-
docrine disrupters and other harmful chemicals must 
ensure that less developed nations have access to 
needed technologies 
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